Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000505905 | SCV000603509 | pathogenic | not specified | 2017-04-11 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001857266 | SCV002239433 | pathogenic | Ellis-van Creveld syndrome; Curry-Hall syndrome | 2023-10-22 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Trp215*) in the EVC2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in EVC2 are known to be pathogenic (PMID: 17024374, 19810119, 19876929). This variant is present in population databases (rs779857359, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with Ellis-van Creveld syndrome (PMID: 22406498). ClinVar contains an entry for this variant (Variation ID: 439673). For these reasons, this variant has been classified as Pathogenic. |